Cencora (COR) Fell Due to Temporary Supply Constraints on Anti-Obesity Drugs
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” second-quarter 2024 investor letter.
Cencora Inc. (COR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 1,345,800 | $303,208,740 | +44% | 0.67% |
| 2. | AQR Capital Management Cliff Asness | 1,084,603 | $244,360,991 | +18% | 0.37% |
| 3. | Millennium Management Israel Englander | 653,011 | $147,123,378 | -34% | 0.06% |
| 4. | Holocene Advisors Brandon Haley | 596,626 | $134,419,838 | +382% | 0.56% |
| 5. | Antipodes Partners Jacob Mitchell | 487,101 | $109,743,855 | -2% | 3.98% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $218.58 | 500 | Director | 21,876 | 2024-05-24 | Filing | |
| $74.33 | 1,350 | Director | 6,717 | 2020-03-23 | Filing | |
| $82.62 | 1,225 | Director | 5,367 | 2020-03-13 | Filing | |
| $80.53 | 11 | Officer | 7,437 | 2019-03-05 | Filing | |
| $88.44 | 10 | Officer | 7,437 | 2018-12-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $241.01 | 21,509 | Officer, Director | 285,088 | 2024-09-17 | Filing | |
| $239.13 | 10,754 | Officer, Director | 285,088 | 2024-08-20 | Filing | |
| $242.69 | 1,473 | Officer | 10,948 | 2024-08-06 | Filing | |
| $240.56 | 4,438,171 | 19,980,000 | 2024-08-01 | Filing | ||
| $222.12 | 10,755 | Officer, Director | 285,088 | 2024-07-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,510,739 | $4,212,495,576 | 0.09% | |
| 2. | 19,677,848 | $4,041,436,442 | 0.1% | |
| 3. | 7,896,643 | $1,621,812,539 | 0.07% | |
| 4. | 5,457,450 | $1,120,851,076 | 0.11% | |
| 5. | 4,624,044 | $949,686,355 | 0.07% |
News See All
Cencora (NYSE:COR) Q3 2024 Earnings Call Transcript
Operator: Good morning and good afternoon, ladies and gentlemen. Welcome to the Cencora Q3 Earnings Call. My name is Jaquita. I will be your moderator for today's call.
Cencora (COR) Rose 19% in Q1
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” first-quarter investor letter. A copy of the letter can be downloaded here.
Cencora (NYSE:COR) Q2 2024 Earnings Call Transcript
Cencora beats earnings expectations. Reported EPS is $3.8, expectations were $3.69.
Cencora (COR) Reported a Strong Q4 and Rose 14%
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
13 Best Pharma Dividend Stocks To Buy in 2024
In this article, we discuss 13 best pharma dividend stocks to buy in 2024.
30 Largest Companies in the World by Revenue
In this article, we will be taking a look at the 30 largest companies in the world by revenue.
Cencora (NYSE:COR) Q1 2024 Earnings Call Transcript
Cencora beats earnings expectations. Reported EPS is $3.28, expectations were $2.85.
Top 30 Largest US Companies by 2023 Revenue
The United States is home to some of the most valuable companies in the world.
Cencora (NYSE:COR) Q4 2023 Earnings Call Transcript
Operator: Hello, everyone, and welcome to the Cencora Q4 Full Year 2023 Earnings Call. My name is Emily, and I'll be coordinating your call today.
Billionaire Hedge Funds
